Raffa R B, Martinez R P
Drug Discovery Research, R. W. Johnson Pharmaceutical Research Institute, Spring House, PA 19477-0776.
Eur J Pharmacol. 1992 May 14;215(2-3):357-8. doi: 10.1016/0014-2999(92)90060-h.
Pretreatment (18 h) of mice with a single s.c. injection of LiCl (10 mmol/kg) reduced the antinociceptive action of centrally administered (i.c.v.) morphine in the tail-flick test (ED50 = 7.7 micrograms) compared to vehicle-treated controls (ED50 = 1.8 micrograms). The coadministration of inositol-1,4,5-trisphosphate (IP3; 20 micrograms) with morphine restored the morphine-induced antinociception (ED50 = 2.4 micrograms) in LiCl-pretreated mice to control levels. These finding implicate a LiCl-sensitive (possibly phosphoinositide) second messenger pathway in the mediation of morphine-induced analgesia.
与赋形剂处理的对照组(半数有效量=1.8微克)相比,单次皮下注射氯化锂(10毫摩尔/千克)对小鼠进行预处理(18小时),可降低在甩尾试验中脑室内注射吗啡的镇痛作用(半数有效量=7.7微克)。在氯化锂预处理的小鼠中,将肌醇-1,4,5-三磷酸(IP3;20微克)与吗啡共同给药,可使吗啡诱导的镇痛作用(半数有效量=2.4微克)恢复至对照水平。这些发现表明,在吗啡诱导的镇痛作用介导过程中,存在一条对氯化锂敏感(可能是磷酸肌醇)的第二信使途径。